| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
An improved Pythium insidiosum-vaccine formulation with enhanced immunotherapeutic properties in horses and dogs with pythiosis
|
Mendoza, Leonel
|
|
2003
|
21 |
21-22 |
p. 2797-2804
8 p.
|
artikel
|
| 2 |
A novel multivalent human CTL peptide construct elicits robust cellular immune responses in HLA-A∗0201 transgenic mice: implications for HTLV-1 vaccine design
|
Sundaram, Roshni
|
|
2003
|
21 |
21-22 |
p. 2767-2781
15 p.
|
artikel
|
| 3 |
A recombinant fowl adenovirus expressing the S1 gene of infectious bronchitis virus protects against challenge with infectious bronchitis virus
|
Johnson, Michael A.
|
|
2003
|
21 |
21-22 |
p. 2730-2736
7 p.
|
artikel
|
| 4 |
A serine proteinase inhibitor (serpin) from ixodid tick Haemaphysalis longicornis; cloning and preliminary assessment of its suitability as a candidate for a tick vaccine
|
Sugino, Maiko
|
|
2003
|
21 |
21-22 |
p. 2844-2851
8 p.
|
artikel
|
| 5 |
A subunit vaccine against the adenovirus egg-drop syndrome using part of its fiber protein
|
Fingerut, E
|
|
2003
|
21 |
21-22 |
p. 2761-2766
6 p.
|
artikel
|
| 6 |
BCG scar and positive tuberculin reaction associated with reduced child mortality in West Africa
|
Garly, May-Lill
|
|
2003
|
21 |
21-22 |
p. 2782-2790
9 p.
|
artikel
|
| 7 |
Call for papers:8-11 November 2003,The Evergreen Conference Resort, Stone Mountain, Georgia, USA
|
|
|
2003
|
21 |
21-22 |
p. I-
1 p.
|
artikel
|
| 8 |
Call for papers: viral vaccine meeting
|
|
|
2003
|
21 |
21-22 |
p. 3094-
1 p.
|
artikel
|
| 9 |
CD40 ligand (CD154) improves the durability of respiratory syncytial virus DNA vaccination in BALB/c mice
|
Harcourt, Jennifer L
|
|
2003
|
21 |
21-22 |
p. 2964-2979
16 p.
|
artikel
|
| 10 |
Chitosan nanoparticles containing plasmid DNA encoding house dust mite allergen, Der p 1 for oral vaccination in mice
|
Chew, Joon Lin
|
|
2003
|
21 |
21-22 |
p. 2720-2729
10 p.
|
artikel
|
| 11 |
Comparison of PorA VR types and porA promoter sequence from Neisseria meningitidis B isolated from non-immunised children and vaccine failures immunised with a serogroup B outer membrane protein vaccine
|
Gorla, Maria Cecı́lia O.
|
|
2003
|
21 |
21-22 |
p. 2871-2876
6 p.
|
artikel
|
| 12 |
Construction and characterization of rhesus monkey rotavirus (MMU18006)- or bovine rotavirus (UK)-based serotype G5, G8, G9 or G10 single VP7 gene substitution reassortant candidate vaccines
|
Hoshino, Yasutaka
|
|
2003
|
21 |
21-22 |
p. 3003-3010
8 p.
|
artikel
|
| 13 |
Correlation of body temperature with protection against staphylococcal enterotoxin B exposure and use in determining vaccine dose-schedule
|
Boles, James W.
|
|
2003
|
21 |
21-22 |
p. 2791-2796
6 p.
|
artikel
|
| 14 |
Corrigendum to “Immunogenic measles antigens expressed in plants: role as an edible vaccine for adults” [Vaccine 21 (2003) 816–819]
|
Muller, Claude P.
|
|
2003
|
21 |
21-22 |
p. 3093-
1 p.
|
artikel
|
| 15 |
CpG oligodeoxynucleotide enhances immunity against blood-stage malaria infection in mice parenterally immunized with a yeast-expressed 19 kDa carboxyl-terminal fragment of Plasmodium yoelii merozoite surface protein-1 (MSP119) formulated in oil-based Montanides
|
Hirunpetcharat, C.
|
|
2003
|
21 |
21-22 |
p. 2923-2932
10 p.
|
artikel
|
| 16 |
DNA vaccination with the immunodominant tachyzoite surface antigen (SAG-1) protects against adult acquired Toxoplasma gondii infection but does not prevent maternofoetal transmission
|
Couper, Kevin N.
|
|
2003
|
21 |
21-22 |
p. 2813-2820
8 p.
|
artikel
|
| 17 |
Editorial Board/Aims and Scope
|
|
|
2003
|
21 |
21-22 |
p. IFC-
1 p.
|
artikel
|
| 18 |
Enhanced adjuvanticity of interleukin-2 plasmid DNA administered in polyethylenimine complexes
|
Oh, Yu-Kyoung
|
|
2003
|
21 |
21-22 |
p. 2837-2843
7 p.
|
artikel
|
| 19 |
Enhancement of Sm-p80 (large subunit of calpain) induced protective immunity against Schistosoma mansoni through co-delivery of interleukin-2 and interleukin-12 in a DNA vaccine formulation
|
Siddiqui, Afzal A.
|
|
2003
|
21 |
21-22 |
p. 2882-2889
8 p.
|
artikel
|
| 20 |
Epidermal powder immunization of mice and monkeys with an influenza vaccine
|
Chen, Dexiang
|
|
2003
|
21 |
21-22 |
p. 2830-2836
7 p.
|
artikel
|
| 21 |
Evaluation of novel aerosol formulations designed for mucosal vaccination against influenza virus
|
Smith, Dan J.
|
|
2003
|
21 |
21-22 |
p. 2805-2812
8 p.
|
artikel
|
| 22 |
Evaluation of synthetic, M type-specific peptides as antigens in a multivalent group A streptococcal vaccine
|
Bruner, M.
|
|
2003
|
21 |
21-22 |
p. 2698-2703
6 p.
|
artikel
|
| 23 |
Evaluation of the compatibility of a second generation recombinant anthrax vaccine with aluminum-containing adjuvants
|
Jendrek, Scott
|
|
2003
|
21 |
21-22 |
p. 3011-3018
8 p.
|
artikel
|
| 24 |
Frequent nasal administrations of recombinant cholera toxin B subunit (rCTB)-containing tetanus and diphtheria toxoid vaccines induced antigen-specific serum and mucosal immune responses in the presence of anti-rCTB antibodies
|
Yasuda, Yoko
|
|
2003
|
21 |
21-22 |
p. 2954-2963
10 p.
|
artikel
|
| 25 |
Gene gun immunization in a preclinical model is enhanced by B7 targeting
|
Tachedjian, Mary
|
|
2003
|
21 |
21-22 |
p. 2900-2905
6 p.
|
artikel
|
| 26 |
Genetic immunization with LYT1 or a pool of trans-sialidase genes protects mice from lethal Trypanosoma cruzi infection
|
Fralish, Bolyn H.
|
|
2003
|
21 |
21-22 |
p. 3070-3080
11 p.
|
artikel
|
| 27 |
Growth phase of orally administered Lactobacillus strains differentially affects IgG1/IgG2a ratio for soluble antigens: implications for vaccine development
|
Maassen, Catharina B.M.
|
|
2003
|
21 |
21-22 |
p. 2751-2757
7 p.
|
artikel
|
| 28 |
Immunity against measles in populations of women and infants in Poland
|
Janaszek, Wieslawa
|
|
2003
|
21 |
21-22 |
p. 2948-2953
6 p.
|
artikel
|
| 29 |
Immunization with recombinant paraflagellar rod protein induces protective immunity against Trypanosoma cruzi infection
|
Luhrs, Keith A.
|
|
2003
|
21 |
21-22 |
p. 3058-3069
12 p.
|
artikel
|
| 30 |
Immunogenicity of a new Salmonella Typhi Vi polysaccharide vaccine—vax-TyVi®—in Cuban school children and teenagers
|
Azze, Rolando Felipe Ochoa
|
|
2003
|
21 |
21-22 |
p. 2758-2760
3 p.
|
artikel
|
| 31 |
Immunogenicity of recombinant HBsAg/HCV particles in mice pre-immunised with hepatitis B virus-specific vaccine
|
Netter, Hans J.
|
|
2003
|
21 |
21-22 |
p. 2692-2697
6 p.
|
artikel
|
| 32 |
Immunogenicity of recombinant Mannheimia haemolytica serotype 1 outer membrane protein PlpE and augmentation of a commercial vaccine
|
Confer, Anthony W.
|
|
2003
|
21 |
21-22 |
p. 2821-2829
9 p.
|
artikel
|
| 33 |
Induction of protective immunity by DNA vaccination with Toxoplasma gondii HSP70, HSP30 and SAG1 genes
|
Mohamed, Rabie M.
|
|
2003
|
21 |
21-22 |
p. 2852-2861
10 p.
|
artikel
|
| 34 |
Intramuscular versus intradermal administration of anti-hepatitis B vaccine in non-cirrhotic hepatitis C patients
|
Arbizu, Eduardo Albéniz
|
|
2003
|
21 |
21-22 |
p. 2747-2750
4 p.
|
artikel
|
| 35 |
Letter to the Editor
|
Kamoltham, Thavatchai
|
|
2003
|
21 |
21-22 |
p. 2691-
1 p.
|
artikel
|
| 36 |
Long-term safety analysis of preventive HIV-1 vaccines evaluated in AIDS vaccine evaluation group NIAID-sponsored Phase I and II clinical trials
|
Gilbert, P.B.
|
|
2003
|
21 |
21-22 |
p. 2933-2947
15 p.
|
artikel
|
| 37 |
Mucosal co-administration of cholera toxin and influenza virus hemagglutinin-DNA in ponies generates a local IgA response
|
Soboll, G.
|
|
2003
|
21 |
21-22 |
p. 3081-3092
12 p.
|
artikel
|
| 38 |
Non-responders to egg grown influenza vaccine seroconvert after booster immunization with MDCK cell grown vaccine
|
Oxford, John S
|
|
2003
|
21 |
21-22 |
p. 2743-2746
4 p.
|
artikel
|
| 39 |
Optimising vaccination strategies in equine influenza
|
Park, A.W.
|
|
2003
|
21 |
21-22 |
p. 2862-2870
9 p.
|
artikel
|
| 40 |
Optimization of epicutaneous immunization for the induction of CTL
|
Kahlon, Roopjeet
|
|
2003
|
21 |
21-22 |
p. 2890-2899
10 p.
|
artikel
|
| 41 |
Oral immunisation with live aroA attenuated Salmonella enterica serovar Typhimurium expressing the Yersinia pestis V antigen protects mice against plague
|
Garmory, Helen S
|
|
2003
|
21 |
21-22 |
p. 3051-3057
7 p.
|
artikel
|
| 42 |
Pathogenicity and neurovirulence of a mutagen-attenuated Rift Valley fever vaccine in rhesus monkeys
|
Morrill, J.C
|
|
2003
|
21 |
21-22 |
p. 2994-3002
9 p.
|
artikel
|
| 43 |
Porcine Ig isotypes: function and molecular characteristics
|
Crawley, A.
|
|
2003
|
21 |
21-22 |
p. 2911-2922
12 p.
|
artikel
|
| 44 |
Protective efficacy of oral immunization with heat-killed Shigella flexneri 2a in animal model: study of cross protection, immune response and antigenic recognition
|
Mukhopadhaya, A
|
|
2003
|
21 |
21-22 |
p. 3043-3050
8 p.
|
artikel
|
| 45 |
Reflections on the meningococcal group C infection immunisation campaign: views from the sharp end
|
Lansley, M
|
|
2003
|
21 |
21-22 |
p. 2877-2881
5 p.
|
artikel
|
| 46 |
Regional, but not systemic recruitment/expansion of dendritic cells by a pluronic-formulated Flt3-ligand plasmid with vaccine adjuvant activity
|
Sang, Hongxun
|
|
2003
|
21 |
21-22 |
p. 3019-3029
11 p.
|
artikel
|
| 47 |
Response of calves persistently infected with noncytopathic bovine viral diarrhea virus (BVDV) subtype 1b after vaccination with heterologous BVDV strains in modified live virus vaccines and Mannheimia haemolytica bacterin-toxoid
|
Fulton, Robert W.
|
|
2003
|
21 |
21-22 |
p. 2980-2985
6 p.
|
artikel
|
| 48 |
Standardisation and establishment of a rabies ELISA test in European laboratories for assessing the efficacy of oral fox vaccination campaigns
|
Cliquet, Florence
|
|
2003
|
21 |
21-22 |
p. 2986-2993
8 p.
|
artikel
|
| 49 |
The immunogenicity of oral poliomyelitis vaccine in a primary vaccination series at 2, 4 and 6 months given concurrently with Hib, hepatitis B and diphtheria, tetanus and whole-cell pertussis vaccines administered as three separate injections or as a combination pentavalent vaccine
|
Hogg, Katharine
|
|
2003
|
21 |
21-22 |
p. 2906-2910
5 p.
|
artikel
|
| 50 |
Theoretic coverage of heptavalent pneumococcal conjugate vaccine in the prevention of community-acquired pneumonia in children in Italy
|
Esposito, Susanna
|
|
2003
|
21 |
21-22 |
p. 2704-2707
4 p.
|
artikel
|
| 51 |
The predicted impact of private sector MMR vaccination on the burden of Congenital Rubella Syndrome
|
Vynnycky, E.
|
|
2003
|
21 |
21-22 |
p. 2708-2719
12 p.
|
artikel
|
| 52 |
The protective efficacy of MSP4/5 against lethal Plasmodium chabaudi adami challenge is dependent on the type of DNA vaccine vector and vaccination protocol
|
Rainczuk, A
|
|
2003
|
21 |
21-22 |
p. 3030-3042
13 p.
|
artikel
|
| 53 |
10 year assessment of infant hepatitis B vaccination program, in the Loyalty Islands (New Caledonia)
|
Berlioz-Arthaud, Alain
|
|
2003
|
21 |
21-22 |
p. 2737-2742
6 p.
|
artikel
|
Tijdschrift beschrijving